A.H. Robins Co., a Richmond, Va.-based pharmaceutical...

A.H. Robins Co., a Richmond, Va.-based pharmaceutical company, which is reorganizing under federal bankruptcy laws, reported that first-quarter net income was up by nearly 17% from the same period last year, to $26 million, compared to $22.3 million a year earlier. Sales were $209.8 million, up 10%, and operating earnings were $47.8 million, up 12%. Costs associated with the company’s Chapter 11 bankruptcy filing reduced net income by $2.6 million in the first quarter, Robins said. Consumer products such as Robitussin cough medicines and Dimetapp cold and allergy products contributed to much of the increased sales and earnings, according to E. Claiborne Robins Jr., the company’s president and chief executive officer.